Thus, the in vitro and in vivo experiments were performed and disclosed that the NeuroD1 was significantly reduced in T2D models, which could be partly reversed by Ex-4 (Fig. 7). This evidence concerns the gene NEUROD1 and type 2 diabetes mellitus.